On the public citation graph

A New Protocol for Predicting Novel GSK-3β ATP Competitive Inhibitors

https://doi.org/10.1021/ci2001154

0 signed · 69 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cmdc.200500039openalex-snapshot

Highly Potent and Specific GSK‐3β Inhibitors That Block Tau Phosphorylation and Decrease α‐Synuclein Protein Expression in a Cellular Model of Parkinson's Disease

inferredcites →https://doi.org/10.1002/j.1460-2075.1990.tb07419.xopenalex-snapshot

Molecular cloning and expression of glycogen synthase kinase‐3/factor A.

inferredcites →https://doi.org/10.1002/med.10011openalex-snapshot

Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

inferredcites →https://doi.org/10.1002/qsar.200390007openalex-snapshot

The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models

inferredcites →https://doi.org/10.1002/qsar.200730052openalex-snapshot

QSAR Models for Prediction of Glycogen Synthase Kinase‐3β Inhibitory Activity of Indirubin Derivatives

inferredcites →https://doi.org/10.1007/bf00124364openalex-snapshot

Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA

inferredcites →https://doi.org/10.1007/bf02815006openalex-snapshot

Glycogen synthase kinase 3 alteration in alzheimer disease is related to neurofibrillary tangle formation

inferredcites →https://doi.org/10.1007/s10822-008-9244-1openalex-snapshot

Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking

inferredcites →https://doi.org/10.1016/0304-419x(92)90012-nopenalex-snapshot

Glycogen synthase kinase-3: functions in oncogenesis and development

inferredcites →https://doi.org/10.1016/j.bmc.2006.03.009openalex-snapshot

QSAR modeling of the inhibition of Glycogen Synthase Kinase-3

inferredcites →https://doi.org/10.1016/j.bmc.2006.09.021openalex-snapshot

Probing the physicochemical and structural requirements for glycogen synthase kinase-3α inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides

inferredcites →https://doi.org/10.1016/j.bmcl.2004.10.060openalex-snapshot

3D QSAR studies on GSK-3 inhibition by aloisines

inferredcites →https://doi.org/10.1016/j.bmcl.2004.12.063openalex-snapshot

The development of potent and selective bisarylmaleimide GSK3 inhibitors

inferredcites →https://doi.org/10.1016/j.ejmech.2005.10.018openalex-snapshot

3D QSAR for GSK-3β inhibition by indirubin analogues

inferredcites →https://doi.org/10.1016/j.ejmech.2007.06.016openalex-snapshot

Selectivity criterion for pyrazolo[3,4-b]pyrid[az]ine derivatives as GSK-3 inhibitors: CoMFA and molecular docking studies

inferredcites →https://doi.org/10.1016/j.jmgm.2006.08.009openalex-snapshot

3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3β inhibitors

inferredcites →https://doi.org/10.1016/s0040-4039(01)94977-9openalex-snapshot

A new model for calculating atomic charges in molecules

inferredcites →https://doi.org/10.1016/s0065-230x(02)84007-6openalex-snapshot

Role of glycogen synthase kinase-3 in cancer: Regulation by Wnts and other signaling pathways

inferredcites →https://doi.org/10.1016/s0079-6468(08)70281-9openalex-snapshot

6 Multivariate Data Analysis and Experimental Design in Biomedical Research

inferredcites →https://doi.org/10.1016/s1093-3263(01)00123-1openalex-snapshot

Beware of q2!

inferredcites →https://doi.org/10.1016/s1471-4914(01)02266-3openalex-snapshot

Glycogen synthase kinase 3: an emerging therapeutic target

inferredcites →https://doi.org/10.1021/ci050008yopenalex-snapshot

3D-QSAR and Docking Studies of Selective GSK-3β Inhibitors. Comparison with a Thieno[2,3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3β Ligands

inferredcites →https://doi.org/10.1021/cr000110oopenalex-snapshot

Glycogen Synthase Kinase-3: Properties, Functions, and Regulation

inferredcites →https://doi.org/10.1021/ja00226a005openalex-snapshot

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

inferredcites →https://doi.org/10.1021/jm00007a003openalex-snapshot

Cross-Validated R2-Guided Region Selection for Comparative Molecular Field Analysis: A Simple Method To Achieve Consistent Results

inferredcites →https://doi.org/10.1021/jm00050a010openalex-snapshot

Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity

inferredcites →https://doi.org/10.1021/jm0308904openalex-snapshot

Evaluation and Comparison of 3D-QSAR CoMSIA Models for CDK1, CDK5, and GSK-3 Inhibition by Paullones

inferredcites →https://doi.org/10.1021/jm040895gopenalex-snapshot

SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

inferredcites →https://doi.org/10.1021/jm801317hopenalex-snapshot

From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors That Suppress Proliferation and Survival of Pancreatic Cancer Cells

inferredcites →https://doi.org/10.1038/35017574openalex-snapshot

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

inferredcites →https://doi.org/10.1038/378785a0openalex-snapshot

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

inferredcites →https://doi.org/10.1074/jbc.274.25.17934openalex-snapshot

The Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism

inferredcites →https://doi.org/10.1074/jbc.m905336199openalex-snapshot

Wnt Signaling to β-Catenin Involves Two Interactive Components

inferredcites →https://doi.org/10.1093/protein/gzi074openalex-snapshot

Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses

inferredcites →https://doi.org/10.1111/j.1471-4159.2004.02422.xopenalex-snapshot

Glycogen synthase kinase 3: a drug target for CNS therapies

inferredcites →https://doi.org/10.1242/jcs.00384openalex-snapshot

GSK-3: tricks of the trade for a multi-tasking kinase

inferredcites →https://doi.org/10.1358/dnp.2003.16.9.829337openalex-snapshot

Glycogen synthase kinase-3 as drug target: From wallflower to center of attention

inferredcites →https://doi.org/10.1517/14728222.12.10.1265openalex-snapshot

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

inferredcites →https://doi.org/10.2337/diabetes.49.2.263openalex-snapshot

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/ejoc.201600923openalex-snapshot

Cu/Ag‐Cocatalyzed Aerobic Oxidative Amination and CuCl2‐Mediated Aerobic Oxidative Chloroamination of Maleimides

inferred← citeshttps://doi.org/10.1007/978-3-032-09153-6_3openalex-snapshot

Developing a Framework Driven by Analytics to Forecast the Binding Free Energy Level and, Consequently, the New Inhibitor Nature of Medicinal Chemical Compounds

inferred← citeshttps://doi.org/10.1007/s00044-019-02311-xopenalex-snapshot

3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments

inferred← citeshttps://doi.org/10.1007/s00706-012-0816-3openalex-snapshot

In silico classification and virtual screening of maleimide derivatives using projection to latent structures discriminant analysis (PLS-DA) and hybrid docking

inferred← citeshttps://doi.org/10.1007/s11030-014-9561-3openalex-snapshot

Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery

inferred← citeshttps://doi.org/10.1007/s12272-020-01216-3openalex-snapshot

Single enzyme nanoparticle, an effective tool for enzyme replacement therapy

inferred← citeshttps://doi.org/10.1007/s12272-020-01230-5openalex-snapshot

3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase

inferred← citeshttps://doi.org/10.1016/b978-0-323-91294-5.00008-7openalex-snapshot

Structure-related relationship: Plant-derived antidiabetic compounds

inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107378openalex-snapshot

Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach

inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2025.108478openalex-snapshot

Identification of novel ligands against GSK-3β: Molecular docking, ADMET filtering, MD simulations, MM-GBSA studies, and DFT analysis

inferred← citeshttps://doi.org/10.1016/j.compbiomed.2015.07.004openalex-snapshot

Monte Carlo method based QSAR modeling of maleimide derivatives as glycogen synthase kinase-3β inhibitors

inferred← citeshttps://doi.org/10.1021/ci400322jopenalex-snapshot

Discovery of New Selective Human Aldose Reductase Inhibitors through Virtual Screening Multiple Binding Pocket Conformations

inferred← citeshttps://doi.org/10.1021/ci400331popenalex-snapshot

Predictions of BuChE Inhibitors Using Support Vector Machine and Naive Bayesian Classification Techniques in Drug Discovery

inferred← citeshttps://doi.org/10.1021/ci500574nopenalex-snapshot

Discovery of Multitarget-Directed Ligands against Alzheimer’s Disease through Systematic Prediction of Chemical–Protein Interactions

inferred← citeshttps://doi.org/10.1021/jm301189copenalex-snapshot

Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design

inferred← citeshttps://doi.org/10.1038/srep21826openalex-snapshot

Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease

inferred← citeshttps://doi.org/10.1039/c3md00397copenalex-snapshot

Scaffold hopping of potential anti-tumor agents by WEGA: a shape-based approach

inferred← citeshttps://doi.org/10.1039/c4ob00589aopenalex-snapshot

Mechanistic studies for tri-targeted inhibition of enzymes involved in cholesterol biosynthesis by green tea polyphenols

inferred← citeshttps://doi.org/10.1039/d3ob01765fopenalex-snapshot

Developing a straightforward route toward the synthesis of arylaminomaleimides by palladium-catalyzed arylation of one-pot synthesized aminomaleimides

inferred← citeshttps://doi.org/10.1080/17460441.2016.1216967openalex-snapshot

Getting the most out of PubChem for virtual screening

inferred← citeshttps://doi.org/10.1111/cbdd.12425openalex-snapshot

In vitro Antiviral Effects and 3 D QSAR Study of Resveratrol Derivatives as Potent Inhibitors of Influenza H 1 N 1 Neuraminidase

inferred← citeshttps://doi.org/10.1111/cbdd.12913openalex-snapshot

(Z)‐2‐(3‐Chlorobenzylidene)‐3,4‐dihydro‐N‐(2‐methoxyethyl)‐3‐oxo‐2H‐benzo[b][1,4]oxazine‐6‐carboxamide as GSK ‐3β inhibitor: Identification by virtual screening and its validation in enzyme‐ and cell‐based assay

inferred← citeshttps://doi.org/10.1371/journal.pone.0102212openalex-snapshot

Insights into the Interactions between Maleimide Derivates and GSK3β Combining Molecular Docking and QSAR

inferred← citeshttps://doi.org/10.1517/17460441.2014.909404openalex-snapshot

Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

inferred← citeshttps://doi.org/10.1517/17460441.2016.1118046openalex-snapshot

QSAR studies in the discovery of novel type-II diabetic therapies

inferred← citeshttps://doi.org/10.2174/1381612811319260007openalex-snapshot

Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements

inferred← citeshttps://doi.org/10.2174/1570159x15666170823095628openalex-snapshot

In Silico Studies in Drug Research Against Neurodegenerative Diseases

inferred← citeshttps://doi.org/10.3390/molecules23112919openalex-snapshot

Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease

inferred← citeshttps://doi.org/10.3724/sp.j.1249.2012.05438openalex-snapshot

3D-QSAR studies on pyrimidine analogues as cyclin-dependent kinase 1 inhibitors

inferred← citeshttps://doi.org/10.5935/2595-4407/rac.immes.v2n2p133-156openalex-snapshot

Compostos bioativos e seus alvos terapêuticos com propriedade Anti-Alzheimer: Uma revisão da literatura

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.